In the latest example of tertiary targeting, animal liberationist radicals are threatening the shareholders of a company that does business with Huntingdon Life Sciences. The threat here is to sell the shares of the “offending” company or else the terrorists will publish the names of existing shareholders for targeting by extremists. The intent is to drive the shares of the company down in order to induce it to quit doing business with Huntingdon. Such is the state of the animal liberation movement that you will here nary a word by fellow travelers condemning this strongly implied threat of harm.
“1st May 2006
Dear Sir/Madam,
We are a group set up to hold Huntingdon Life Sciences (HLS) accountable for it’s acts of animal cruelty.
Holding HLS accountable means holding GlaxoSmithKline to it’s promise not to use HLS ever again following the TV documentary ‘Countryside Undercover’ showing workers punching beagle puppies.
The only way to hold GlaxoSmithKline to it’s PROMISE is to target it’s financial vulnerability. We are therefore giving you this opportunity to sell your shares in GlaxoSmithKline.
Over the next two weeks every shareholder of GlaxoSmithKline will be receiving this letter. If you have any doubts over the effectiveness of this action then keep a close eye on the GSK share price and watch it plummet.
This was a tactic used against HLS shareholders which saw its share price nose dive from the LSE and NYSE. To this day they are still unable to trade on the stock market. [See here, for the story on the intimidation of the New York Stock Exchange.]
The second time this tactic was used was against Montpellier PLC, a building contractor employed to build an animal testing laboratory for Oxford University. Their share price plummeted, a leading director resigned and within weeks they had withdrawn their services, leaving the site of the proposed laboratory for 18 months with no building work being carried out on it.
Should you choose not to sell your shares with in the next 14 days your details will be publicised and within weeks a website will be hosted with all remaining shareholders listed.
To avoid this please email GSKshareholder1860@hotmail.com confirming you have sold, within the next 14 days. We will be checking that you have done this.
The choice is yours”
Dear Reader,
Can I be direct with you?
War abroad. Socialists on the rise. AI upending human life. Endless uproar online. The modern attention economy doesn’t want readers — it wants users enslaved to the tyranny of the present.
First Things is the antidote: literary excellence, timeless truths, and a fixed point of reference in a culture that has lost its bearings.
But we can’t do it without readers like you.
Our goal: Raise $150,000 by November 1 to sustain First Things in the year ahead.
Your gift anchors readers in the permanent things.
Make your Fall Campaign gift now using the button below.
If you have any questions or would like more information, please contact Giovanni Del Piero, Director of the Editor’s Circle, at gdelpiero@firstthings.com or 212-627-1985.
YOU MIGHT ALSO LIKE
The Church in the Age of Therapy
In 1966, Philip Rieff wrote in The Triumph of the Therapeutic that “Religious man was born to…
Canada’s Deadliest Blind Spot
On September 20, the Daily Mail ran a story with the provocative headline, “Our 83-year-old Christian grandmother…
The Faithful Joy of Dolly Parton and Fulton Sheen
Dolly Parton and Fulton Sheen seem to have had little in common. She favored rhinestones; he wore…
